ABL Bio Inc. (298380.KQ)
KRW 27400.0
(-5.03%)
KRW 27400.0
(-5.03%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 65.54 Billion | 67.3 Billion | 5.33 Billion | 8.1 Billion | 3.98 Billion | 1.25 Billion |
| Cost of Revenue | 46.24 Million | 21.74 Billion | 26.53 Billion | 11.22 Billion | 8.92 Billion | 3.5 Billion |
| Gross Profit | 65.5 Billion | 45.56 Billion | -21.2 Billion | -3.12 Billion | -4.94 Billion | -2.24 Billion |
| Operating Expenses | 65.52 Billion | 44.65 Billion | 29.98 Billion | 57.83 Billion | 35.51 Billion | 21.79 Billion |
| Selling, General and Administrative Expenses | 7.94 Billion | 6.39 Billion | 2.99 Billion | 5.03 Billion | 4.32 Billion | 3.7 Billion |
| Research and Development Expenses | 52.03 Billion | 38.26 Billion | 26.99 Billion | 52.79 Billion | 31.19 Billion | 18.09 Billion |
| Other Expenses | - | 2.4 Billion | 1.03 Billion | -1.04 Billion | - | - |
| Cost and Expenses | 65.57 Billion | 66.39 Billion | 56.52 Billion | 69.06 Billion | 44.44 Billion | 25.29 Billion |
| Operating Income | -27.32 Million | 906.48 Million | -51.19 Billion | -60.95 Billion | -40.45 Billion | -24.03 Billion |
| Interest Expense | 2.15 Billion | 1.32 Billion | 41.97 Million | 72.85 Million | 90.73 Million | 680.94 Million |
| Income Tax Expense | - | 5.00 | -5.00 | 4.00 | 4.00 | 2.00 |
| Earnings before Tax | -2.64 Billion | 3.2 Billion | -43.55 Billion | -55.6 Billion | -37 Billion | -117.23 Billion |
| Net Income | -2.64 Billion | 3.2 Billion | -43.55 Billion | -55.6 Billion | -37 Billion | -117.23 Billion |
| Earnings Per Share Basic | -55.32 | 67.46 | -927.36 | -1207.19 | -818.27 | -3804.17 |
| Earnings Per Share Diluted | -55.32 | 67.46 | -927.36 | -1207.19 | -818.27 | -3804.17 |
| Weighted Average Shares Outstanding | 47.84 Million | 47.56 Million | 46.96 Million | 46.06 Million | 45.22 Million | 30.81 Million |
| Weighted Average Shares Outstanding (Diluted) | 47.84 Million | 47.56 Million | 46.96 Million | 46.06 Million | 45.22 Million | 30.81 Million |
| Gross Margin | 1.00 | 0.68 | -3.98 | -0.39 | -1.24 | -1.78 |
| EBIT Margin | 0.03 | 0.05 | -9.20 | -7.27 | -9.72 | -18.61 |
| Profit Margin | -0.04 | 0.05 | -8.17 | -6.86 | -9.28 | -93.20 |
| EBITDA | 2.1 Billion | 6.86 Billion | -41.35 Billion | -53.46 Billion | -35.23 Billion | -115.92 Billion |
| Earnings Before Tax Margin | -0.00 | 0.01 | -9.60 | -7.52 | -10.14 | -19.11 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 8.44 Billion | 7.93 Billion | 8 Billion | 65.54 Billion | 8.57 Billion | 8.59 Billion |
| Cost of Revenue | 3.89 Billion | 6.26 Billion | 7.05 Billion | 24.19 Billion | 5.76 Billion | 5.67 Billion |
| Gross Profit | 4.54 Billion | 1.67 Billion | 952.33 Million | 41.35 Billion | 2.8 Billion | 2.91 Billion |
| Operating Expenses | 15.83 Billion | 15.95 Billion | 11.14 Billion | 43.97 Billion | 7.99 Billion | 13.26 Billion |
| Selling, General and Administrative Expenses | 1.47 Billion | 2.72 Billion | 1.81 Billion | - | 1.33 Billion | 992.12 Million |
| Research and Development Expenses | 14.35 Billion | 13.23 Billion | 9.33 Billion | - | 6.66 Billion | 12.26 Billion |
| Other Expenses | -23.83 Million | 194.26 Million | -1.27 Billion | -1.49 Billion | 122.07 Million | -31.15 Million |
| Cost and Expenses | 19.72 Billion | 22.21 Billion | 18.19 Billion | 68.17 Billion | 13.76 Billion | 18.93 Billion |
| Operating Income | -11.28 Billion | -14.27 Billion | -10.19 Billion | -2.62 Billion | -5.19 Billion | -10.34 Billion |
| Interest Expense | 6.97 Million | 482.99 Million | 183.04 Million | 2.15 Billion | 651.32 Million | 643.08 Million |
| Income Tax Expense | 5.00 | -3.00 | -2.00 | -4.00 | 3.00 | -4.00 |
| Earnings before Tax | -11.4 Billion | -11.97 Billion | -12.51 Billion | -2.64 Billion | -4.1 Billion | -10.35 Billion |
| Net Income | -11.4 Billion | -11.97 Billion | -12.51 Billion | -2.64 Billion | -4.1 Billion | -10.35 Billion |
| Earnings Per Share Basic | -237.93 | -249.96 | -261.28 | - | -85.85 | -216.57 |
| Earnings Per Share Diluted | -237.93 | -249.96 | -261.28 | - | -85.85 | -216.57 |
| Weighted Average Shares Outstanding | 47.95 Million | 47.89 Million | 47.89 Million | 47.84 Million | 47.86 Million | 47.82 Million |
| Weighted Average Shares Outstanding (Diluted) | 47.95 Million | 47.89 Million | 47.89 Million | 47.84 Million | 47.86 Million | 47.82 Million |
| Gross Margin | 0.54 | 0.21 | 0.12 | 0.63 | 0.33 | 0.34 |
| EBIT Margin | -1.27 | -1.72 | -1.19 | - | -0.53 | -1.13 |
| Profit Margin | -1.35 | -1.51 | -1.56 | -0.04 | -0.48 | -1.21 |
| EBITDA | -10.69 Billion | -13.63 Billion | -9.56 Billion | - | -4.53 Billion | -9.69 Billion |
| Earnings Before Tax Margin | -1.34 | -1.80 | -1.27 | -0.04 | -0.61 | -1.20 |
BPCGF
KPIGREEN
1938
GNHRF
000719
TOAGF